COMMUNIQUÉS West-GlobeNewswire

Daxor Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference
03/09/2024
Oak Ridge, TN, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh will present at the H [...]
Informations relatives au nombre total de droits de vote et d’actions composant le capital
03/09/2024
Informations relatives au nombre total de droits de vote et d’actions composant le capital Nantes, le 3 septembre 2024 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement [...]
Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device
02/09/2024
Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device FDA regulatory submission for the Company’s Genio® device is complete, U.S. approval on track for the end [...]
Nyxoah Sonne la Cloche de Clôture sur le Nasdaq alors qu'elle se Prépare à Lancer sa Technologie Innovante pour l'Apnée du Sommeil sur le Marché Américain
02/09/2024
Nyxoah Sonne la Cloche de Clôture sur le Nasdaq alors qu'elle se Prépare à Lancer sa Technologie Innovante pour l'Apnée du Sommeil sur le Marché Américain L'entreprise a complété la demande d'enregistrement [...]
Trading by management and close relations of management
02/09/2024
Please read the full announcement in PDF Attachment 2024_31_Trading_By_Management
Trading by management and close relations of management
02/09/2024
Please read the full announcement in PDF Attachment 2024_30_Trading_By_Management
Amended terms of Idorsia’s 2024 convertible bonds become effective
02/09/2024
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – September 2, 2024 Idorsia Ltd (SIX: IDIA) today announced that following the expiry of the appeal period – during which no appeal was filed – the [...]
Claritas NucMed Technologies Secures Approval for its Subsidiary Claritas NucMed Tech Brazil to Forge Ahead the Commercialization of its Cutting-Edge Nuclear Medicine Software Solutions in Brazil
02/09/2024
LONDON and SAO PAULO, Sept. 02, 2024 (GLOBE NEWSWIRE) -- Claritas NucMed Technologies Ltd (“Claritas NucMed”), a company specializing in image processing, lesion detection and quantification for the nuclear medicine [...]
ESC Congress 2024: INFINITY-SWEDEHEART Trial of Elixir Medical’s DynamX Bioadaptor Meets Primary Endpoint and Clinical Results Confirm Unique Mechanism of Action
02/09/2024
ESC Congress 2024: INFINITY-SWEDEHEART Trial of Elixir Medical’s DynamX Bioadaptor Meets Primary Endpoint and Clinical Results Confirm Unique Mechanism of Action —Largest randomized data set to date on bioadaptor, with [...]
Congrès ESC 2024 : L’essai INFINITY-SWEDEHEART portant sur le DynamX Bioadaptor d’Elixir Medical satisfait au critère d’évaluation principal et les résultats cliniques confirment un mécanisme d'action unique
02/09/2024
Congrès ESC 2024 : L’essai INFINITY-SWEDEHEART portant sur le DynamX Bioadaptor d’Elixir Medical satisfait au critère d’évaluation principal et les résultats cliniques confirment un mécanisme d'action unique — Le pool [...]
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/09/2024
CLEVELAND, Sept. 02, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved [...]
Lucinda Crabtree joins Oxford Biomedica as Chief Financial Officer today
02/09/2024
Lucinda Crabtree joins Oxford Biomedica as Chief Financial Officer today Oxford, UK – 2 September 2024: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica”, "OXB" or “the Company”), a quality and innovation-led cell and [...]
GUERBET : Bilan semestriel du contrat de liquidité
02/09/2024
Bilan semestriel du contrat de liquidité Villepinte, le 2 septembre 2024 Au titre du contrat de liquidité confié par la société GUERBET à Exane BNP Paribas, en date de dénouement du 30 juin 2024, les moyens suivants [...]
Trading in GN Store Nord shares by board members, executives and associated persons
02/09/2024
GN Store Nord has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in GN Store Nord made by persons discharging managerial responsibilities in GN [...]
Myocene Helps the French Handball Team
02/09/2024
LIÈGE, Belgium, Sept. 02, 2024 (GLOBE NEWSWIRE) -- Myocene, the Belgian sportstech company which is developing a device for the objective measurement of muscular fatigue for top-level sportsmen and women, today [...]
Theolytics Awarded Significant £2M Transforming Cancer Therapeutics Grant from Innovate UK
02/09/2024
The funding will support Theolytics’ Phase 1 clinical trial for THEO-260 in ovarian cancer and incorporates comprehensive biomarker studies to showcase the candidate's differentiated dual tumour-lytic and [...]
Myocene Helps the French Handball Team
02/09/2024
LIÈGE, Belgium, Sept. 02, 2024 (GLOBE NEWSWIRE) -- Myocene, the Belgian sportstech company which is developing a device for the objective measurement of muscular fatigue for top-level sportsmen and women, today [...]
MYOCENE AU SERVICE DE L'ÉQUIPE DE FRANCE DE HANDBALL
02/09/2024
LIÈGE, Belgique, 02 sept. 2024 (GLOBE NEWSWIRE) -- Myocene, la sportstech liégeoise qui développe un dispositif de mesure objective de la fatigue musculaire à destination des sportifs de haut niveau, annonce aujourd’hui [...]
PCI Biotech: Employee share option scheme
02/09/2024
Oslo, 2 September 2024 - PCI Biotech (OSE: PCIB), today announce that the Board of Directors has granted share options to key employees. In accordance with the authorisation granted by the Annual General Meeting 24 May [...]

Pages